These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1033536)

  • 1. Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Postgrad Med J; 1976; 52(5 Suppl):136-8. PubMed ID: 1033536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Clin Exp Immunol; 1975 Jul; 21(1):13-22. PubMed ID: 810281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilymphocyte globulin and adrenal steroids in the treatment of multiple sclerosis: short report based on seven cases.
    Cendrowski W
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):339-43. PubMed ID: 553516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical use of antilymphocyte globulin (ALG) (author's transl)].
    Brendel W; Seifert J; Ring J
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1361-8. PubMed ID: 809676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive immunosuppression in the treatment of multiple sclerosis.
    Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
    Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of multiple sclerosis with antilymphocyte serum: results of a pilot study on 50 patients followed-up over a 4-year period (author's transl)].
    Lhermitte F; Marteau R; De Saxce H
    Rev Neurol (Paris); 1979 Jun; 135(5):389-400. PubMed ID: 538387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial results of clinical compatibility testing of antihuman lymphocyte globulin (AHLG-Dessau)].
    Preussner S; Frick G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(1):31-45. PubMed ID: 4118779
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance.
    Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W
    Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.
    Knight SC; Lance EM; Abbosh J; Munro A; O'Brien J
    Clin Exp Immunol; 1975 Jul; 21(1):23-31. PubMed ID: 1181076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.
    Ring J; Seifert J; Anstwurm H; Frick E; Mertin J; Brass B; Backmund H; Lob G
    Postgrad Med J; 1976; 52(5 Suppl):123-30. PubMed ID: 792844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results.
    Simmons RL; Moberg AW; Gewurz H; Soll R; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):745-8. PubMed ID: 4999469
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of immunologic tolerance to antilymphocyte globulin in man.
    Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS
    Surg Forum; 1969; 20():259-61. PubMed ID: 4986402
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antilymphocytic globulin and its immunosuppressive action in experimental allergic encephalomyelitis and multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1972; 6(4):619-23. PubMed ID: 4564004
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of tolerance to horse gamma globulin (HoGG) and antilymphocyte globulin (HoALG) in humans and experimental animals.
    Gewurz H; Moberg AW; Johnson D; Simmons RL; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):737-40. PubMed ID: 4106338
    [No Abstract]   [Full Text] [Related]  

  • 20. The evidence justifying immunosuppression therapy in multiple sclerosis.
    Mertin J
    Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.